VHI Stock Recent News
VHI LATEST HEADLINES
TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has signed a definitive agreement (the “Definitive Agreement”) to acquire MedCurrent Corporation and its subsidiaries (“MedCurrent”), by way of a court-approved plan of arrangement under the provisions of the Business Corporations Act (Ontario) (the “Transaction”).
TORONTO, July 25, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its second quarter 2024 ended June 30th, 2024, after market close on August 8th, 2024. The Company will subsequently hold a conference call via Zoom on August 9th, 2024, at 9:00am EST hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow.
TORONTO, June 03, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF), a leading provider of healthcare technology solutions, is pleased to announce a new partnership with Lumenus Community Services, a prominent Toronto-based organization dedicated to providing comprehensive support services for individuals and families. Lumenus is one of the largest providers of community services in the province, providing a single circle of care and support to their clients.
Dallas, Texas, May 23, 2024 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 27, 2024 to stockholders of record at the close of business on June 10, 2024.
Valhi, Inc. has been a stock market laggard in the last five years, reflecting declining fundamentals. In the last year, the company has improved its profitability and revenues and performed better than the market.
Valhi controls multiple listed companies and relies on their success for its growth. The family-owned company is perfectly aligned with its investors and is poised to generate sizable returns amid its growing Chemical segment.